Latest Financial Milestones News

Galan Lithium has completed a $20 million placement and secured Argentine government incentives, advancing its Hombre Muerto West lithium project toward first production in early 2026.

Novatti Group has achieved positive operating cashflow and EBITDA for the September quarter, driven by strategic revenue reforms and new commercial contracts with major clients.

Auric Mining has successfully completed its first gold pour from the Munda Starter Pit ahead of schedule, setting the stage for imminent gold sales and cash flow. This milestone marks a significant step in Auric’s growth trajectory as it prepares for expanded production in 2026.

ECS Botanics reports a positive cash flow milestone in Q1 FY26, driven by strong direct-to-consumer sales and operational efficiencies, while preparing for a European market debut.

XPON Technologies announces a significant leadership reshuffle with founder Matt Forman stepping down as CEO due to health reasons, while Mark Simari assumes the role of Executive Chair amid strategic growth initiatives.

St Barbara Limited reveals strategic progress on its Simberi Sulphide Expansion and Atlantic Projects, underpinning a robust production outlook and advancing key regulatory approvals.

Polymetals Resources reports steady operational gains at its Endeavor silver-zinc mine, hitting key production and financial milestones including a scheduled first zinc concentrate shipment and inclusion in the ASX All Ordinaries Index.

Triton Minerals has received the final A$8.5 million payment from NQM Gold 2 Pty Ltd under a key settlement agreement, marking a significant financial milestone for the company.

Orthocell Ltd reported a record $9.23 million revenue for FY25, driven by strong sales of its nerve repair and dental products, alongside securing US FDA clearance for its flagship nerve repair device Remplir. The company is poised for accelerated growth as it expands its global commercial footprint.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its plant-based milks and dairy segments. The company has resolved legacy litigation issues and is now focused on navigating the $610 million convertible note maturity due in 2027.

Lumos Diagnostics has submitted its CLIA waiver application for FebriDx® to the FDA, backed by strong clinical data and triggering significant milestone payments. Approval could expand the U.S. market opportunity fifteen-fold to over $1 billion.

Vection Technologies has reported its first positive underlying EBITDA for FY2025, driven by strong growth in its Defence sector. The company sets ambitious FY2026 revenue targets of $70 million, underpinned by a robust $50 million sales pipeline and cutting-edge AI and spatial computing solutions.